Compare Harmony Gold Mining Co. (HMY) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Harmony Gold Mining Co. vs Twist Bioscience Corp — how do they compare? Harmony Gold Mining Co. trades at $15.09 (market cap $9.07B), while Twist Bioscience Corp trades at $94.16 (market cap $5.45B). The key difference: Harmony Gold Mining Co. is the larger of the two by market cap, and Harmony Gold Mining Co. pays a 2.84% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| HMY | TWST | |
|---|---|---|
Market Cap | $9.07B | $5.45B |
Sector | Basic Materials | Health |
52-Week High | $26.04 | $102.88 |
52-Week Low | $12.61 | $24.16 |
Enterprise Value | $9.41B | $5.37B |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Harmony Gold Mining (HMY) trades at $14.37, down 1.91% on the day, amid a bearish technical signal and mixed sentiment. The company shows strong fundamentals with a P/E of 9.37, net income margin of 20.06%, and robust cash flow from operations of $15.65 billion in 2024. Recent earnings beat expectations in Q2 2025 but missed in Q4 2025, while revenue grew to $61.38 billion in 2024. A dividend of $0.31 is scheduled for payment in May 2026, adding income appeal.
Outlook is cautious due to technical weakness and analyst skepticism (70% hold rating), but valuation metrics and profitability support potential upside if gold prices stabilize. Key risks include Fed rate sensitivity and operational execution amid the transition to a gold-copper hybrid model. The stock presents a value opportunity with manageable debt, though near-term volatility may persist.
Twist Bioscience (TWST) trades at $87.41, down 6.86% today, with a bullish technical outlook despite recent earnings misses. The company shows strong revenue growth from $204M in 2022 to $377M in 2025, though it remains unprofitable with a -19.85% net margin. Analyst consensus is strongly bullish with 11 buy ratings and a $91.63 price target, while recent news highlights AI-driven drug discovery collaborations and upcoming Q3 earnings.
The stock presents growth potential through expanding synthetic biology applications and AI partnerships, but carries significant risk from persistent losses, negative cash flow, and high valuation multiples (P/S 13.94). Investors should weigh the company's innovation trajectory against its path to profitability amid competitive biotech pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Harmony Gold Mining Co.
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
Read more on HMY →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
